Skip to content

Jervell And Lange Nielsen Syndrome 2 C2676723

Published: July 22, 2026Updated: August 25, 2026

A genetic subtype of Jervell and Lange Nielsen syndrome linked to KCNE1 gene changes. Presents with congenital hearing loss and cardiac rhythm disturbances.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ventricular tachycardia

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hearing loss

(cardiovascular)

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Beta-blocker therapy

First-line pharmacological treatment using non-selective beta-blockers to reduce sympathetic stimulation and prevent potentially fatal cardiac arrhythmias.

medication
3

Implantable cardioverter-defibrillator (ICD)

Surgical implantation of an ICD for patients at high risk of ventricular arrhythmias or those who have survived cardiac arrest despite beta-blocker therapy.

surgical

Additional treatment options

Activity restriction and trigger avoidance

Lifestyle modifications including avoidance of strenuous exercise, competitive sports, and known QT-prolonging triggers such as certain medications and electrolyte disturbances.

lifestyle

Cochlear implantation

Surgical placement of a cochlear implant to restore auditory function in patients with congenital sensorineural deafness associated with the syndrome.

complementary

Regular cardiac monitoring and genetic screening

Lifelong ECG monitoring, periodic Holter monitoring, and regular cardiology follow-up along with cascade genetic testing for family members.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Jervell And Lange Nielsen Syndrome 2 C2676723?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Jervell And Lange Nielsen Syndrome 2 C2676723. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy